Catalyst
Slingshot members are tracking this event:
Long Term (4year) Data Released of Phase 3 Study for Opko's (OPK) Somatrogon (hGH-CTP), an Investigational Long-Acting Growth Hormone Being Studied for the Treatment of Children With Growth Hormone Deficiency
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| OPK |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 23, 2019
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Somatrogon, Growth Hormone, Growth Hormone Deficiency
